Free Cash Flow (FCF): $972.40M
The free cash flow (FCF) is $972.40M. It is above its 12-month average by 7.58% ($903.87M).
STE Free Cash Flow (FCF)
Reported quarterly free cash flow; no daily interpolation.
STE Quarterly Free Cash Flow Growth (YoY)
Free Cash Flow growth vs the same quarter one year earlier, last 20 quarters.
STE Average Free Cash Flow (FCF) Chart
STE Current vs Average Free Cash Flow (FCF) Chart
STE Free Cash Flow (FCF) Metrics
FREE CASH FLOW (FCF)
$972.40M
FREE CASH FLOW (FCF) AVG TTM
$903.87M
FREE CASH FLOW (FCF) AVG 3Y
$705.01M
FREE CASH FLOW (FCF) AVG 5Y
$598.35M
FREE CASH FLOW (FCF) AVG 10Y
$399.42M
FREE CASH FLOW (FCF) AVG 15Y
$299.80M
FREE CASH FLOW (FCF) AVG 20Y
$250.37M
CURRENT VS TTM AVG
+7.58%
CURRENT VS 3Y AVG
+37.93%
CURRENT VS 5Y AVG
+62.51%
CURRENT VS 10Y AVG
+143.45%
CURRENT VS 15Y AVG
+224.35%
CURRENT VS 20Y AVG
+288.39%
FCF Analysis
Free Cash Flow (TTM)
$972.40M
FCF Yield
4.69%
Price/FCF
21.3
Formula: FCF = Operating Cash Flow - Capital Expenditures
Why FCF matters:
- Shows actual cash available (not accounting earnings)
- Funds dividends, buybacks, and debt reduction
- Less susceptible to accounting manipulation than net income
- Key metric for DCF valuation models
Free Cash Flow (FCF) Formula & Definition
Free Cash Flow represents the cash a company generates after accounting for capital expenditures. It's the cash available for dividends, buybacks, debt reduction, or reinvestment.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Free Cash Flow (FCF) FAQ
- What is the free cash flow (FCF) for STERIS plc (STE)?
- The free cash flow (FCF) for STE stock is $972.40M.
- What is the TTM average free cash flow (FCF) for STERIS plc (STE)?
- The TTM average free cash flow (FCF) for STE stock is $903.87M.
- What is the 3Y average free cash flow (FCF) for STERIS plc (STE)?
- The 3Y average free cash flow (FCF) for STE stock is $705.01M.
- What is the 5Y average free cash flow (FCF) for STERIS plc (STE)?
- The 5Y average free cash flow (FCF) for STE stock is $598.35M.
- What is the 10Y average free cash flow (FCF) for STERIS plc (STE)?
- The 10Y average free cash flow (FCF) for STE stock is $399.42M.
- What is the 15Y average free cash flow (FCF) for STERIS plc (STE)?
- The 15Y average free cash flow (FCF) for STE stock is $299.80M.
- What is the 20Y average free cash flow (FCF) for STERIS plc (STE)?
- The 20Y average free cash flow (FCF) for STE stock is $250.37M.
STE Free Cash Flow (FCF) History
| DATE | FREE CASH FLOW (FCF) |
|---|---|
| 2026-03-31 | $972.40M |
| 2025-09-30 | $961.20M |
| 2025-03-31 | $778.00M |
| 2024-09-30 | $680.11M |
| 2024-03-31 | $612.95M |
| 2023-09-30 | $535.44M |
| 2023-03-31 | $394.98M |
| 2022-09-30 | $398.72M |
| 2022-03-31 | $397.25M |
| 2021-09-30 | $400.45M |
| 2021-03-31 | $450.38M |
| 2020-09-30 | $399.54M |
| 2020-03-31 | $376.04M |
| 2019-09-30 | $347.47M |
| 2019-03-31 | $349.79M |
| 2018-09-30 | $314.37M |
| 2018-03-31 | $292.18M |
| 2017-09-30 | $278.51M |
| 2017-03-31 | $251.19M |
| 2016-09-30 | $203.36M |
| 2016-03-31 | $128.27M |
| 2015-09-30 | $131.95M |
| 2015-03-31 | $160.78M |
| 2014-09-30 | $158.71M |
| 2014-03-31 | $123.26M |
| 2013-09-30 | $106.38M |
| 2013-03-31 | $140.40M |
| 2012-09-30 | $123.56M |
| 2012-03-31 | $82.69M |
| 2011-09-30 | $37.28M |
| 2011-03-31 | $40.30M |
| 2010-09-30 | $136.12M |
| 2010-03-31 | $180.87M |
| 2009-09-30 | $152.54M |
| 2009-03-31 | $126.50M |
| 2008-09-30 | $103.11M |
| 2008-03-31 | $86.43M |
| 2007-09-30 | $81.01M |
| 2007-03-31 | $46.72M |
| 2006-09-30 | $46.04M |
| 2006-03-31 | $110.78M |
| 2005-09-30 | $120.96M |
| 2005-03-31 | $95.22M |
| 2004-09-30 | $92.18M |
| 2004-03-31 | $55.09M |
| 2003-09-30 | $42.82M |
| 2003-03-31 | $74.70M |
Related Metrics
About STERIS plc
STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Daniel A. Carestio